Bio Path Correlations

BPTH Stock  USD 0.81  0.01  1.54%   
The current 90-days correlation between Bio Path Holdings and Diffusion Pharmaceuticals is 0.1 (i.e., Average diversification). The correlation of Bio Path is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Bio Path Correlation With Market

Average diversification

The correlation between Bio Path Holdings and DJI is 0.16 (i.e., Average diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Bio Path Holdings and DJI in the same portfolio, assuming nothing else is changed.
  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Bio Path Holdings. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.

Moving against Bio Stock

  0.57EHC Encompass Health Corp Earnings Call This WeekPairCorr
  0.55CVS CVS Health Corp Earnings Call This WeekPairCorr
  0.51SEM Select Medical HoldingsPairCorr
  0.44MD Mednax IncPairCorr
  0.43EHAB EnhabitPairCorr
  0.36BMY Bristol Myers Squibb Earnings Call This WeekPairCorr
  0.73VLY Valley National BancorpPairCorr
  0.52BRK-B Berkshire HathawayPairCorr
  0.51ACW Actinogen MedicalPairCorr
  0.45300871 Wuhan Hvsen BiotechnologyPairCorr
  0.43NRG NRG EnergyPairCorr
  0.42688670 Jiangsu GDK BiotechnologyPairCorr
  0.4688217 Shanghai RightongenePairCorr
  0.31300942 Shenzhen Bioeasy BioPairCorr

Related Correlations Analysis

Click cells to compare fundamentals   Check Volatility   Backtest Portfolio

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.
High positive correlations   
ALRNBLPH
BLPHNXTC
ALRNNXTC
CRNXDFFN
BLPHCAPR
NXTCCAPR
  
High negative correlations   
CRNXCBIO
NXTCCBIO
DFFNCBIO
ALRNCBIO
PULMNXTC
BLPHCBIO

Risk-Adjusted Indicators

There is a big difference between Bio Stock performing well and Bio Path Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Bio Path's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Mean DeviationJensen AlphaSortino RatioTreynor RatioSemi DeviationExpected ShortfallPotential UpsideValue @RiskMaximum Drawdown
CBIO  4.25  0.95  0.13  5.97  4.45 
 9.76 
 38.47 
DFFN  2.40 (0.56) 0.00 (0.95) 0.00 
 4.09 
 12.34 
CAPR  3.76 (0.45) 0.00 (0.36) 0.00 
 8.11 
 32.30 
NXTC  3.02 (0.82) 0.00 (0.56) 0.00 
 6.74 
 24.13 
PULM  6.31  2.82  0.47 (1.10) 4.08 
 16.69 
 92.85 
BLPH  5.45 (2.28) 0.00 (1.02) 0.00 
 7.64 
 105.97 
CRNX  2.34 (0.62) 0.00 (0.47) 0.00 
 3.10 
 21.52 
AMTI  5.08  0.29  0.01 (0.15) 5.70 
 11.11 
 36.60 
ALRN  4.00 (0.57) 0.00 (1.18) 0.00 
 8.06 
 24.38 
BNTC  3.14  0.12  0.00 (0.15) 3.90 
 7.89 
 22.11 

Bio Path Corporate Management

Michael MBAVP OperationsProfile
Alan MacKenzieConsultantProfile
Thomas WalkerConsultantProfile
MBA AshizawaDevelopment ResearchProfile
Peter MBAChairman, CoFounderProfile
Jeffery MDConsultantProfile
Victoria RacRegulatory ConsultantProfile